This ETF Should Like the Intercept Pharma News
January 30, 2015 at 06:00 AM EST
Shares of Intercept Pharmaceuticals (NasdaqGS: ICPT) surged nearly 29% during Thursday’s after-hours session after the company investigational product obeticholic acid (OCA) landed “breakthrough therapy designation” from the U.S. Food and Drug Administration (FDA) for the treatment of...
